Healthcare provider profile · identity verified

Stuart David Cataldo, MD

Internal Medicine · EUREKA, CA · NPI 1962507590

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	692	188
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	414	64
Levothyroxine Sodium	Levothyroxine Sodium	311	82
Losartan Potassium	Losartan Potassium	311	88
Amlodipine Besylate	Amlodipine Besylate	284	84
Lisinopril	Lisinopril	246	74
Gabapentin	Gabapentin	234	52
Pantoprazole Sodium	Pantoprazole Sodium	227	59
Metoprolol Succinate	Metoprolol Succinate	210	69
Eliquis	Apixaban	208	39
Omeprazole	Omeprazole	179	48
Metformin Hcl	Metformin Hcl	170	52
Simvastatin	Simvastatin	162	41
Furosemide	Furosemide	151	43
Tamsulosin Hcl	Tamsulosin Hcl	148	46
Potassium Chloride	Potassium Chloride	136	32
Rosuvastatin Calcium	Rosuvastatin Calcium	127	38
Duloxetine Hcl	Duloxetine Hcl	124	30
Lorazepam	Lorazepam	109	36
Albuterol Sulfate Hfa	Albuterol Sulfate	107	42
Alendronate Sodium	Alendronate Sodium	96	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	96	26
Spironolactone	Spironolactone	90	29
Zolpidem Tartrate	Zolpidem Tartrate	89	14
Alprazolam	Alprazolam	85	16
Clonazepam	Clonazepam	76	12
Trazodone Hcl	Trazodone Hcl	74	21
Allopurinol	Allopurinol	70	20
Morphine Sulfate Er	Morphine Sulfate	69	suppressed
Trulicity	Dulaglutide	68	11
Montelukast Sodium	Montelukast Sodium	67	20
Tizanidine Hcl	Tizanidine Hcl	66	11
Triamcinolone Acetonide	Triamcinolone Acetonide	65	30
Warfarin Sodium	Warfarin Sodium	64	12
Benazepril Hcl	Benazepril Hcl	60	14
Ozempic	Semaglutide	59	11
Oxycodone Hcl	Oxycodone Hcl	54	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	53	17
Xarelto	Rivaroxaban	53	suppressed
Donepezil Hcl	Donepezil Hcl	52	15
Metoprolol Tartrate	Metoprolol Tartrate	52	18
Aripiprazole	Aripiprazole	51	suppressed
Carvedilol	Carvedilol	50	15
Escitalopram Oxalate	Escitalopram Oxalate	50	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	14
Temazepam	Temazepam	46	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	46	suppressed
Finasteride	Finasteride	45	13
Fluticasone Propionate	Fluticasone Propionate	45	18
Sertraline Hcl	Sertraline Hcl	45	14
Tramadol Hcl	Tramadol Hcl	45	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	45	14
Amiodarone Hcl	Amiodarone Hcl	43	suppressed
Metformin Hcl Er	Metformin Hcl	43	13
Propranolol Hcl Er	Propranolol Hcl	43	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	15
Pravastatin Sodium	Pravastatin Sodium	41	11
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	11
Clopidogrel	Clopidogrel Bisulfate	38	13
Ezetimibe	Ezetimibe	36	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	36	suppressed
Atenolol	Atenolol	33	11
Jardiance	Empagliflozin	32	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	17
Baclofen	Baclofen	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Famotidine	Famotidine	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Rizatriptan	Rizatriptan Benzoate	28	suppressed
Prednisone	Prednisone	27	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	25	25
Propranolol Hcl	Propranolol Hcl	25	suppressed
Diazepam	Diazepam	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Estradiol	Estradiol	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Ondansetron Odt	Ondansetron	23	11
Advair Hfa	Fluticasone Propion/Salmeterol	22	suppressed
Eszopiclone	Eszopiclone	22	suppressed
Glipizide	Glipizide	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Nitroglycerin	Nitroglycerin	22	12
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	15
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Oxycontin	Oxycodone Hcl	21	suppressed
Premarin	Estrogens, Conjugated	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Azithromycin	Azithromycin	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	14
Midodrine Hcl	Midodrine Hcl	18	suppressed
Risperidone	Risperidone	18	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Klor-Con 10	Potassium Chloride	16	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Belsomra	Suvorexant	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	11
Carisoprodol	Carisoprodol	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Valproic Acid	Valproic Acid	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Colchicine	Colchicine	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error